News
)
30 January 2023
VIVEbiotech interview on Labiotech.eu from Florida
Labiotech.eu interviewed Natalia Elizalde during Phacilitate’s Advanced Therapies Week congress that took place last week in Miami Beach, Florida.
Read more)
26 January 2023
VIVEbiotech featured in a Drug Discovery World guide
Natalia Elizalde and Naiara Tejados have participated in a Drug Discovery World cell and gene therapy guide that was recently published.
Read more)
9 January 2023
Article on lentiviral vector therapies in-vivo and ex-vivo in The Medicine Maker
Naiara Tejados, Head of Marketing and Technology Development, has published an article in The Medicine Maker entitled “Know Your Vectors: a 101 on Lentiviral Therapies”.
Read more)
23 December 2022
Merry Christmas and Happy New Year!
All the VIVEbiotech team wishes you a very Merry Christmas and a wonderful 2023!
Read more)
16 December 2022
VIVEbiotech collaborates in the 4th edition of the ADEGI´s INDUSTRIA EGUNA
VIVEbiotech has participated in the 4th edition of the INDUSTRIA EGUNA organised by ADEGI - Business Association of Gipuzkoa.
Read more)
15 November 2022
Successful participation of VIVEbiotech in international events in 2022
VIVEbiotech has successfully participated in 7 international events during 2023.
Read more)
11 November 2022
VIVEbiotech presents its highly flexible and customized approach to lentiviral vector manufacturing at BioProcess International
VIVEbiotech has presented a webinar entitled “Flexible and Customized Approach to Lentiviral Vector Development and Manufacture Through a Well-Established Platform” last Tuesday, November 8.
Read more)
24 October 2022
VIVEbiotech participates in the 4th edition of New Culturers Gunea
VIVEbiotech has participated in the 4th edition of New Culturers Gunea that took place in FabrikaNCE last 19th October: a very interesting event to show...
Read more)
21 October 2022
Gurutz Linazasoro, CEO of VIVEbiotech, participates in a conference organized by AseBio and CIBER
Gurutz Linazasoro, CEO of VIVEbiotech, has participated in the conference called "Terapias avanzadas (TA): de la academia a la industria" organized by AseBio, the Spanish...
Read more)
19 October 2022
VIVEbiotech presents its highly optimized transfection process in a webinar with Polyplus
VIVEbiotech has participated in a webinar entitled “The importance of raw materials to succeed in lentiviral vector manufacturing” together with Polyplus.
Read moreDestacadas
)
)
)
)
){kind=spacer}
4 March 2024
Spanish researchers to design proteins using AI to make advanced therapies more efficient
)
)
14 February 2024
VIVEbiotech forecasts significant growth in lentiviral vectors and CAR-T therapies for 2024
)
)
9 February 2024
)